Dynamically monitoring pneumonia severity scores to predict the prognosis in patients with community-acquired pneumonia: an international, multicenter cohort study
Abstract
BACKGROUND
Traditional pneumonia severity scores are widely used at treatment initiation to stratify disease severity and predict prognosis. Although they can be reassessed during treatment to evaluate disease progression, their predictive accuracy remains suboptimal. To address this limitation, we introduce a novel machine learning algorithm that quantifies continuous disease progression, enhancing real-time evaluation of treatment efficacy and outcome prediction in community-acquired pneumonia (CAP).
METHODS
We analyzed 2052 CAP patients from China and 1862 from Japan. CURB-65 and pneumonia severity index (PSI) scores were recorded at admission and 72 h post-treatment. To quantify disease progression, we developed a new algorithm, Mortality Vector Optimization (MVO), which measures the similarity between a patient's condition and critical states within severity scoring systems. Model discrimination was assessed using the C-index and AUC, while calibration was evaluated with Brier scores. External validation was conducted using the GOSSIS-1-eICU and SCRIPT CarpeDiem datasets.
RESULTS
MVO demonstrated superior predictive performance compared to nine established machine learning models. In the derivation cohort, MVO achieved a C-index of 0.734 and AUC of 0.825 for PSI, while in the GOSSIS-1-eICU dataset, it reached a C-index of 0.850 and AUC of 0.870. The trend score derived from MVO effectively captured disease progression, with hazard ratios of 2.63 (for CURB-65) and 2.50…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 2,052 participants or records.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.